Clinical Trial Update: Safety and Efficacy of Vilazodone in Pediatric Patients With Major Depressive Disorder (VLZ-MD-22) [Phase 3]

View source ↗

Summary

Phase 3 clinical trial updates safety and efficacy of vilazodone in pediatric patients with major depressive disorder; results completed with posted results in …

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Major Depressive Disorder

Drugs mentioned

• Vilazodone (vilazodone)

Snippet

Sponsor: Forest Laboratories | Conditions: Major Depressive Disorder | Phase 3 | Status: COMPLETED | Results posted: 2019-10-01